These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23019013)

  • 21. HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells.
    Maxwell PJ; Gallagher R; Seaton A; Wilson C; Scullin P; Pettigrew J; Stratford IJ; Williams KJ; Johnston PG; Waugh DJ
    Oncogene; 2007 Nov; 26(52):7333-45. PubMed ID: 17533374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer.
    Devapatla B; Sharma A; Woo S
    PLoS One; 2015; 10(9):e0139237. PubMed ID: 26414070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases.
    Varney ML; Singh S; Li A; Mayer-Ezell R; Bond R; Singh RK
    Cancer Lett; 2011 Jan; 300(2):180-8. PubMed ID: 21035946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy.
    Agarwal A; Tressel SL; Kaimal R; Balla M; Lam FH; Covic L; Kuliopulos A
    Cancer Res; 2010 Jul; 70(14):5880-90. PubMed ID: 20570895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma.
    Grépin R; Guyot M; Giuliano S; Boncompagni M; Ambrosetti D; Chamorey E; Scoazec JY; Negrier S; Simonnet H; Pagès G
    Cancer Res; 2014 Feb; 74(3):873-83. PubMed ID: 24335961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.
    Gabellini C; Trisciuoglio D; Desideri M; Candiloro A; Ragazzoni Y; Orlandi A; Zupi G; Del Bufalo D
    Eur J Cancer; 2009 Sep; 45(14):2618-27. PubMed ID: 19683430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.
    Maxwell PJ; Coulter J; Walker SM; McKechnie M; Neisen J; McCabe N; Kennedy RD; Salto-Tellez M; Albanese C; Waugh DJ
    Eur Urol; 2013 Aug; 64(2):177-88. PubMed ID: 22939387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
    Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
    Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
    Maxwell PJ; Neisen J; Messenger J; Waugh DJ
    Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment.
    Zhang T; Tseng C; Zhang Y; Sirin O; Corn PG; Li-Ning-Tapia EM; Troncoso P; Davis J; Pettaway C; Ward J; Frazier ML; Logothetis C; Kolonin MG
    Nat Commun; 2016 May; 7():11674. PubMed ID: 27241286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells.
    Thobe MN; Gurusamy D; Pathrose P; Waltz SE
    Oncogene; 2010 Jan; 29(2):214-26. PubMed ID: 19838218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments.
    Dufies M; Grytsai O; Ronco C; Camara O; Ambrosetti D; Hagege A; Parola J; Mateo L; Ayrault M; Giuliano S; Grépin R; Lagarde N; Montes M; Auberger P; Demange L; Benhida R; Pagès G
    Theranostics; 2019; 9(18):5332-5346. PubMed ID: 31410218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.
    Krishnan B; Torti FM; Gallagher PE; Tallant EA
    Prostate; 2013 Jan; 73(1):60-70. PubMed ID: 22644934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells.
    Salcedo R; Resau JH; Halverson D; Hudson EA; Dambach M; Powell D; Wasserman K; Oppenheim JJ
    FASEB J; 2000 Oct; 14(13):2055-64. PubMed ID: 11023990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of recombinant human CXCL8(3-72)K11R/G31P on atherosclerotic plaques in a mouse model of atherosclerosis.
    Qin Y; Mao W; Pan L; Sun Y; Fan F; Zhao Y; Cui Y; Wei X; Kohama K; Li F; Gao Y
    Immunopharmacol Immunotoxicol; 2019 Jun; 41(3):446-454. PubMed ID: 31124391
    [No Abstract]   [Full Text] [Related]  

  • 36. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer.
    Chen C; Xu ZQ; Zong YP; Ou BC; Shen XH; Feng H; Zheng MH; Zhao JK; Lu AG
    Cell Death Dis; 2019 Feb; 10(3):178. PubMed ID: 30792394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer.
    Murphy C; McGurk M; Pettigrew J; Santinelli A; Mazzucchelli R; Johnston PG; Montironi R; Waugh DJ
    Clin Cancer Res; 2005 Jun; 11(11):4117-27. PubMed ID: 15930347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human CXCL8(3-72)K11R/G31P regulates smooth muscle cell proliferation and migration through blockage of interleukin-8 receptor.
    Qin Y; Fan F; Zhao Y; Cui Y; Wei X; Kohama K; Gordon JR; Li F; Gao Y
    IUBMB Life; 2013 Jan; 65(1):67-75. PubMed ID: 23281038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
    Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
    Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCL8((3-73))K11R/G31P antagonizes the neutrophil chemoattractants present in pasteurellosis and mastitis lesions and abrogates neutrophil influx into intradermal endotoxin challenge sites in vivo.
    Li F; Zhang X; Mizzi C; Gordon JR
    Vet Immunol Immunopathol; 2002 Nov; 90(1-2):65-77. PubMed ID: 12406656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.